Suchergebnisse - "Alotaibi, Ahmad S"

PubPharm (4)

1

Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 inhibitors

enthalten in: Blood cancer discovery | 2021

von Alotaibi, A. | Yilmaz, M. | Kanagal-Shamanna, R. | +24

CommentIn: Blood Cancer Discov. 2020 Dec 06;2(2):113-115. - PMID 34661152

2

Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations

enthalten in: Cancer | 2021

von Shoukier, M. | Kadia, T. | Konopleva, M. | +21

3

Clonal evolution with acquisition of BCR-ABL1 in refractory acute myeloid leukemia post therapy with FLT3-inhibitor

enthalten in: Leukemia & lymphoma | 2020

von Thakral, B. | Daver, N. | Tang, Z. | +8

4

Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML

enthalten in: Journal of hematology & oncology | 2020

von Yilmaz, M. | Alfayez, M. | DiNardo, C. | +22

ErratumIn: J Hematol Oncol. 2021 Feb 23;14(1):34. - PMID 33618754

1
[1]